Smit Giri MD MHS
@smith__giri
Followers
439
Following
737
Media
4
Statuses
525
Medical Oncologist & Hematologist | PhD candidate @uabsoph | interested in caring for older adults with cancer
Hamden, CT
Joined December 2017
RT @mtmdphd: Underutilization of guideline‐rec supportive care among older adults w/ myeloma in US [Aug 5, 2019] @smith__giri et al @Journa….
acsjournals.onlinelibrary.wiley.com
Among 1996 older adults in the United States who were receiving multiple myeloma–directed therapy, fewer than two-thirds received bone-modifying drugs within the first year of their diagnosis, and...
0
2
0
RT @JGeriOnc: Geriatric assessment-identified impairments and frailty in adults with cancer younger than 65: An opportunity to optimize onc….
0
19
0
RT @JGeriOnc: Racial differences in body composition and survival among older adults with gastrointestinal malignancies .
0
8
0
RT @PavlosMsaouel: @SuyogCancer @ASCO @OncoAlert @DrChoueiri @tompowles1 @montypal @dr_yakupergun @DrYukselUrun To help find the answer the….
0
1
0
RT @5_utr: 💯 Real world evidence is marketing terminology for the old “observational evidence” and implies that somehow RCTs don’t happen i….
0
3
0
RT @PavlosMsaouel: Further discussion on this topic in the #DataMethods forum here: @f2harrell @Lester_Domes.
discourse.datamethods.org
Extremely helpful again. My informal take on the Ivermectin literature, having been one of the lead statisticians on two Ivermectin RCTs, is that Ivermectin has a beneficial effect that happens to be...
0
3
0
RT @PavlosMsaouel: 👇Thoroughly enjoyed this outstanding paper @IanMarschner. Perhaps a useful interpretation of Conf(BENEFIT)=0.94 is that….
bmcmedresmethodol.biomedcentral.com
Background Researchers often misinterpret and misrepresent statistical outputs. This abuse has led to a large literature on modification or replacement of testing thresholds and P-values with...
0
2
0
RT @Richard_D_Riley: Personal reflection: "Clinical prediction models & the multiverse of madness". Thanks to @BMCMedicine for 'getting thi….
bmcmedicine.biomedcentral.com
Background Each year, thousands of clinical prediction models are developed to make predictions (e.g. estimated risk) to inform individual diagnosis and prognosis in healthcare. However, most are not...
0
16
0
RT @mendel_random: A short 1984 chapter by Richard Peto on "The need for ignorance in cancer research" republished today .
link.springer.com
European Journal of Epidemiology - During the early 1980s both cancer biology and epidemiological methods were being transformed. In 1984 the leading cancer epidemiologist Richard Peto – who,...
0
15
0
RT @PavlosMsaouel: Pleased to share our latest article on why and how drug dose-finding can be tailored to each patient’s risk-benefit trad….
0
10
0
RT @andrew02114: @awechalekar @ash2023 Here's a link to the abstract referenced Looking forward to seeing the prese….
0
6
0
RT @rajshekharucms: This trial serves as an important reminder for the fact that ixazomib should have NO role in post-transplant maintenanc….
0
8
0
RT @cecilia_lund3: Halv the older patients with gi cancers experience dizziness and walking impairments after chemotherapy, but it is under….
0
2
0
RT @EnriqueSoto8: Hot off the press the new @ASCO @myESMO global curriculum recommendations for Cancer Care in Older Adults #gerionc .Every….
0
54
0
RT @MaartenvSmeden: In a couple of years we will talk about risk factor studies -- putting in a bunch of covariates in a multivariable regr….
0
74
0
RT @Mohty_EBMT: 1/⚠️Important need to knowℹ️ for using BCMA-directed agents in #MultipleMyeloma. @NoopurRajeMD and myself.have u covered.👇#….
0
13
0
RT @mmejia91: . This could be improved by:.1) improved PK/PD leading to improved exposure (AUC .2) Improved supportive care (30% of Mel200….
0
1
0